Evidence that Par-4 participates in the pathogenesis of HIV encephalitis

Citation
Ii. Kruman et al., Evidence that Par-4 participates in the pathogenesis of HIV encephalitis, AM J PATH, 155(1), 1999, pp. 39-46
Citations number
35
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Journal title
AMERICAN JOURNAL OF PATHOLOGY
ISSN journal
00029440 → ACNP
Volume
155
Issue
1
Year of publication
1999
Pages
39 - 46
Database
ISI
SICI code
0002-9440(199907)155:1<39:ETPPIT>2.0.ZU;2-L
Abstract
Progressive neuronal degeneration in brain regions involved in learning and memory processes is a common occurrence in patients infected with human im munodeficiency virus type 1 (HIV-1). We now report that levels of Par-4, a protein recently linked to neuronal apoptosis in Alzheimer's disease, are i ncreased in neurons in hippocampus of human patients with HIV encephalitis and in monkeys infected with a chimeric strain of HIV-1 and simian immunode ficiency virus. Par-4 levels Increased rapidly in cultured hippocampal neur ons following exposure to the neurotoxic HIV-1 protein Tat, and treatment o f the cultures with a Par-4 antisense oligonucleotide protected the neurons against Tat-induced apoptosis, Additional findings show that Par-4 partici pates at an early stage of Tat-induced neuronal apoptosis before caspase ac tivation, oxidative stress, and mitochondrial dysfunction. Our data suggest that Par-4 may be a mediator of neuronal apoptosis in HIV encephalitis and that therapeutic approaches targeting the Par-4 apoptotic cascade may prov e beneficial in preventing neuronal degeneration and associated dementia in patients infected with HIV-1.